SAN DIEGO, CA – AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will further enhance AnaBios’ unique human tissue and cells portfolio and help scientists expedite drug discovery and further their understanding of cell biology through […]
TOKYO — Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive agreement signed on August 29, 2022. Evident was newly established on April 1, 2022 as a wholly owned subsidiary of Olympus comprising the former Scientific […]
New leadership team, led by Dr Ben Cliff, will drive growth in pharmaceutical development and discovery & biologics Limerston Capital LLP (Limerston Capital) has announced the acquisition of Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc. The deal will see Concept Life Sciences cement its […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its investment in Wilson Wolf Manufacturing. Wilson Wolf achieved the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne’s initial investment in the company. Bio-Techne’s $257 million investment gives the Company a 20% ownership stake in Wilson […]
France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to […]
Olympus Corporation (“Olympus”) hereby announces that the closing date of the transfer of all shares of Evident Corporation, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) (the “Transfer”) has been scheduled for April 3, […]
Tokyo — Evident Corporation (“Evident”) announces that the closing date of the transfer of all shares of Evident, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) has been scheduled for April 3, 2023. Reasons for […]
Calibre Scientific Acquires SciQuip, a UK Provider of Scientific Equipment, Supplies and Services LOS ANGELES, CA — Calibre Scientific is pleased to announce the acquisition of SciQuip Ltd, a UK based provider of scientific equipment, laboratory supplies and services to customers in the research, university, hospital and biopharma sectors. SciQuip marks Calibre Scientific’s 12th acquisition […]
Brown Gibbons Lang & Company (BGL) is a leading investment banking and financial advisory firm, is pleased to announce the sale of lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, to Miltenyi Biotec, a global biotech company based in Germany. BGL’s Diagnostics, Research Tools & Medical Devices investment banking […]
Today, LGC announced the acquisition of Lipomed AG’s reference materials business including standards with drugs of abuse and toxicology applications, and thus greatly complementing LGC’s reference standards offering. Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
